Project Details
Description
A Phase 2, Multi-Center ... Study to Assess Safety and Immunogenicity of Three Doses of 3'-aminomethylnicotine-P. aeruginosa r-Exoprotein A Conjugate Vaccine (NicVAX) ...
| Status | Finished |
|---|---|
| Effective start/end date | 4/19/06 → 9/30/08 |
Funding
- NABI
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.